Novo Nordisk Stock Surge 2025: NVO Shares Jump 9% on FDA Approval of Oral Wegovy Weight Loss Pill
Novo Nordisk A/S (NYSE: NVO) shares rocketed more than 9% in premarket trading on December 23, 2025, extending gains after the U.S. Food and Drug Administration approved an oral version of the company’s blockbuster Wegovy obesity treatment, marking the first-ever […]










